Table 1.
Descriptive, clinical, hemodynamic characterization and renal and electrolyte profiles of effective donors
| Variable | Result (N=305) |
|---|---|
| Age (years) | 41.45±14.1 |
| Race | |
| Caucasian | 220 (72.0) |
| Black | 28 (9.0) |
| Asian | 3 (0.9) |
| Pardo (mixed race) | 54 (17.0) |
| Male | 167 (55) |
| History | |
| Overweight | 95 (31.15) |
| HTN | 82 (27.0) |
| DFDR | 42 (14.0) |
| Obesity | 23 (7.55) |
| DM | 13 (4.3) |
| Habits | |
| Tobacco use | 60 (19.7) |
| Alcoholism | 57 (18.7) |
| Drug addiction | 27 (8.8) |
| Hemodynamics | |
| VAG | 283 (92.7) |
| Noradrenaline | 249 (81.6) |
| Dose (mcg/kg/min) | 0.21 (0.001-3.25) |
| Dopamine | 73 (24.0) |
| Dose (mcg/kg/min) | 7 (0.1-20.0) |
| Dobutamine | 9 (3.0) |
| Dose (mcg/kg/min) | 7.5 (4.0-10.0) |
| Vasopressin | 2 (0.65) |
| Dose (U/min) | 0.44 (0.4-0.48) |
| Renal profile | |
| Creatinine (mg/dL) | 0.93±0.11 |
| Urea (mg/dL) | 47±29.3 |
| Electrolyte profile | |
| Sodium (mEq/L) | 160.42±16.1 |
| Potassium (mEq/L) | 3.33±1.0 |
| Glucose (mg/dL) | 162.5±86.0 |
HTN - hypertension; DFDR - first-degree relatives with diabetes mellitus, DM - diabetes mellitus; VAG - vasoactive drugs. Results are expressed as number (percentage), mean±standard deviation or median (minimum–maximum).